Please click on the link just before the start of the webinar
A spotlight on Global Health: Learn about research and programs aimed at improving health outcomes in areas of need through collaborations in low- and middle-income countries.
This seminar will provide an update on progress to introduce the dapivirine vaginal ring and injectable cabotegravir into PrEP programmes, with a particular focus on sub-Saharan Africa and other low- and middle-income country settings.
Professor Sinead Delany-Moretlwe
Sinead Delany-Moretlwe, MBBCh PhD DTM&H is a Research Professor and Director: Research, Wits RHI at the University of the Witwatersrand, Johannesburg. Her research interests span the intersections between sexual and reproductive health and infectious diseases, particularly in adolescent girls and young women. She has worked on several phase III trials of new HIV prevention technologies, including oral, topical and most recently long-acting injectable PrEP.
Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.